1 min read

ID: 259594

Discovery Date: 29 June 2022, 07:25:28 UTC

Published Date: NaT

Source: European Clinical Trials Register

Link: https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002625-29

Abstract

EudraCT Number: 2019-002625-29
Sponsor Protocol Number: GWSP19066
Sponsor Name: GW Pharma Limited
Start Date: 2020-01-14
Medical condition: Symptomatic treatment of spasticity in patients with multiple sclerosis (MS)
Disease:
Version: 20.0
SOC Term: 10029205 - Nervous system disorders
Classification Code: 10028335
Term: Muscle spasticity
Level: PT
Version: 20.1
SOC Term: 10029205 - Nervous system disorders
Classification Code: 10028245
Term: Multiple sclerosis
Level: PT

Population Age: Adults, Elderly
Gender: Male, Female
Trial Protocol: PL (Ongoing), GB (GB - no longer in EU/EEA), CZ (Completed)

Noun Phrases in Title

This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.